[ALA] YoY Quarter Result on 31-Mar-2013 [#Q3]

Stock
[ALA] Arovella Therapeutics Limited
Announcement Date
30-Mar-2013
Financial Year
2013
Quarter
31-Mar-2013 [#Q3]
Profit Trend
QoQ- 27.33%
YoY-
Quarter Report
ALA's Result
ALA's Financial Summary
View:
Show?
Quarter Result
31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 CAGR
Revenue 198 43 1,875 1,511 1,407 1,256 985 -23.45%
PBT -3,925 -2,276 -501 -621 -1,039 -955 -438 44.09%
Tax 463 -373 340 383 329 90 87 32.11%
NP -3,462 -1,903 -161 -238 -711 -860 -351 46.41%
Tax Rate - - - - - - - -
Total Cost 3,660 1,946 2,036 1,749 2,118 2,116 1,335 18.29%
Ratio Analysis
31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 CAGR
NP Margin -1,748.22 -4,437.93 -8.58 -15.73 -50.56 -68.49 -35.61 91.29%
Per Share
31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 CAGR
EPS -0.03 -0.04 -0.00 -0.01 -0.02 -0.03 -0.01 20.08%
EPS Diluted -0.03 -0.04 -0.00 -0.01 -0.02 -0.03 -0.01 20.08%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.